Ugmad, Bb Boy .

HRN: 28-79-36  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2026
AMPICILLIN 250MG (VIAL)
04/04/2026
04/10/2026
IV
110mg
Q12
RDS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: